Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

New Elite Feature: Find Similar Charts in Seconds

Tvardi Therapeutics

Contributing Author

Recent Articles by Tvardi Therapeutics

Sep-24	New Preclinical Data Further Support Potential for Tvardi's STAT3 Inhibitors in Ulcerative Colitis (UC) TVRD -19.70% GlobeNewswire
Aug-26	Tvardi Therapeutics to Participate in Upcoming Investor Events TVRD GlobeNewswire
Aug-14	Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update TVRD +7.34% GlobeNewswire
Aug-12	Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026 TVRD GlobeNewswire
Jul-30	Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109 TVRD GlobeNewswire
Jul-07	Tvardi Therapeutics' TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement TVRD +54.23% GlobeNewswire
May-21	Tvardi Therapeutics to Participate in Upcoming Investor Events TVRD -6.75% GlobeNewswire
May-08	Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update TVRD GlobeNewswire
Apr-02	Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium TVRD GlobeNewswire
Mar-31	Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update TVRD TVRD -5.66% GlobeNewswire
Feb-12	Tvardi Therapeutics to Participate in Upcoming Investor Conferences TVRD GlobeNewswire
Jan-08	Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference TVRD +8.74% TVRD +7.57% GlobeNewswire
Jan-08	Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights TVRD +8.74% GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)